Annual Drug Patent Expirations for SYMJEPI
Symjepi is a drug marketed by Adamis Pharms Corp and is included in one NDA.
The generic ingredient in SYMJEPI is epinephrine. Additional details are available on the epinephrine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
